Join us at the IASLC 2023 Targeted Therapies of Lung Cancer Meeting
Why Attend TTLC 2023?
Presentations will summarize information about ongoing clinical trials of the newest therapies for lung cancer including data on preclinical and early clinical data.
Present & Discuss
Showcase your research and contribute to discussions that will shape the future of treatments in lung cancer and thoracic malignancies.
Advertising, Promotion & Exhibits
Market to one of the most unique gatherings of researchers, clinicians and professionals in the field of lung cancer and thoracic oncology.
|November 1, 2022||Abstract Submission Opens|
|November 28, 2022||Registration & Accommodation Opens|
|December 2, 2022 |
|Abstract Submission Deadline|
|December 20, 2022||Abstract Notifications of Acceptance/Rejection|
|January 20, 2023||Presenting Author Registration Deadline|
|January 20, 2023||Accommodation Booking Deadline|
|February 22 – 25, 2023||Meeting|
The Scientific Program Committee for the IASLC 2023 Targeted Therapies of Lung Cancer Meeting is inviting the submission of scientific abstracts.
Join us for TTLC 2023
The IASLC Targeted Therapies of Lung Cancer Meeting features novel research on emerging combination immunotherapy approaches and targets.
We look forward to seeing you in Santa Monica, CA